Neurological Disorders

Market Movers
Neurological Disorders

Intra-Cellular Therapies, Inc. (ITCI): CAPLYTA’s Role in Bipolar Therapy

Intra-Cellular Therapies, Inc. (ITCI) is at the forefront of innovative treatments for serious psychiatric and neurological disorders. Specializing in mental health solutions, ITCI develops advanced therapeutics that address conditions such as schizophrenia, bipolar depression, and other mood disorders. Its flagship product, CAPLYTA (lumateperone), is an FDA-approved treatment for schizophrenia and bipolar depression. Designed to improve […]

Read More
© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.